ANN WEBER: Open Payments
NPI 1073932026 · CINCINNATI, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,639 in 140 payments from 21 companies in 2025. Trend: 2023 $1,895 · 2024 $2,010 · 2025 $2,639
Food & beverage: $2,524Education: $115
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 18 | $405 |
| Teva Pharmaceuticals USA, Inc. | 12 | $344 |
| Otsuka America Pharmaceutical, Inc. | 23 | $308 |
| ABBVIE INC. | 22 | $228 |
| Neurocrine BioSciences, Inc. | 8 | $188 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $174 |
| Lundbeck LLC | 7 | $160 |
| Collegium Pharmaceutical, Inc. | 7 | $121 |
| Axsome Therapeutics, Inc. | 6 | $120 |
| Indivior Inc. | 4 | $95 |
Products named: ARISTADA, VRAYLAR, ABILIFY MAINTENA, INGREZZA, CAPLYTA, REXULTI, Jornay PM, Auvelity.
Industry payments across OH — which companies pay providers there.
